4 results match your criteria: "Burn Center with Plastic Surgery[Affiliation]"
Int Wound J
October 2020
Plastic Surgery Department and Burn Unit, Soroka University Medical Center, Faculty of Health Sciences, Ben Gurion University of the Negev, Beer Sheba, Israel.
NexoBrid (NXB) has been proven to be an effective selective enzymatic debridement agent in adults. This manuscript presents the combined clinical trial experience with NXB in children. Hundred and ten children aged 0.
View Article and Find Full Text PDFBurns
June 2020
BG Trauma Center, Hand-, Plastic and Reconstructive Surgery, Microsurgery, Burn Center, University of Heidelberg, Ludwigshafen, Germany.
Introduction: Bromelain-based Enzymatic Debridement has been introduced as an additional concept to the burn surgeon's armamentarium and is best indicated for mid-to deep dermal burns with mixed patterns. Increasing evidence has been published focusing on special regions and settings as well as on limitations of Enzymatic Debridement to improve patient care. To better guide Enzymatic Debridement in view of the increasing experience, there is a need to update the formerly published consensus guidelines with user-orientated recommendations, which were last produced in 2017.
View Article and Find Full Text PDFBurns
June 2019
Burn Center with Plastic Surgery, Unfallkrankenhaus Berlin, Germany. Electronic address:
Burns
December 2017
BG Trauma Center, Hand-, Plastic and Reconstructive Surgery, Burn Center, University of Heidelberg, Ludwigshafen, Germany.
Early debridement and/or eschar removal is regarded as a significant step in the treatment of deep partial and full thickness burns. It aims to control wound bioburden and allows early wound closure by conservative treatment or skin grafting. Preservation of viable dermis accompanied by early wound closure, is regarded as a necessary step to reduce scar related complication, e.
View Article and Find Full Text PDF